Found 6 matching trials
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE3 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria PHASE2 This study was designed to evaluate the effectiveness and safety of mFOLFOX...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE2 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC PHASE3 This is a multi-center randomized phase III clinical study of first-line in...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC PHASE2 This is a prospective, one-arm, phase II clinical study of intravenous mFOL...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC PHASE3 This is a multi-center randomized phase III clinical study of first-line Ca...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial